Matches in Library of Congress for { <http://lccn.loc.gov/76010396> ?p ?o. }
Showing items 1 to 25 of
25
with 100 items per page.
- 76010396 contributor B2822178.
- 76010396 contributor B2822179.
- 76010396 created "1976.".
- 76010396 date "1976".
- 76010396 date "1976.".
- 76010396 dateCopyrighted "1976.".
- 76010396 description "Includes bibliographies and indexes.".
- 76010396 description "Kety, S.S. Introduction.--Tipton, K. F., Houslay, M.D., and Mantle, T.J. The nature and locations of the multiple forms of monamine oxidase.--Maycock, A.L. et al. The action of acetylenic inhibitors on mitochondrial monoamine oxidase: structure of the flavin site in the inhibited enzyme.--Salach, J.I. et al. Cysteinyl flavin in monamine oxidase from the central nervous system.--Gorkin, V.Z. Monoamine oxidase inhibitors and the transformation of monoamine oxidases.--Sourkes, T.L. and Missala, K. Nutritional requirements for amine metabolism in vivo.--Youdim, M.B.H. and Holzbauer, M. Physiological aspects of the oxidative deamination of monoamines.--Knoll, J. Analysis of the pharmacological effects of selective monoamine oxidase inhibitors.--Neff, N.H. and Fuentes, J.A. The use of selective monoamine oxidase inhibitor drugs for evaluating pharmacological and physiological mechanisms.--Trendelenburg, U., Graefe, K.H., and Henseling, M. The part played by monoamine oxidase in the inactivation of catecholamines in intact tissues.--Sharman, D.F. Can the intra- and extra-homoneuronal metabolism of catecholamines be distinguished in the mammalian central nervous system?--Green, A.R. and Youdim, M.B.H. Use of a behavioural model to study the action of monoamine oxidase inhibition in vivo.--Maitre, L., Delini-Stula, A., and Waldmeier, P.C. Relations between the degree of monoamine oxidase inhibition and some psychopharmacological responses to monoamine oxidase inhibitors in rats.--Pare, C.M.B. Introduction to clinical aspects of monoamine oxidase inhibitors in the treatment of depression.--Roth, M. et al. The relationship between classification and response to drugs in affective disorders--problems posed by drug response in affective disorders.--Sandler, M. Variations in monoamine oxidase activity in some human disease states.--Murphy, D.L. Clinical, genetic, hormonal and drug influences on the activity of human platelet monoamine oxidase activity in schizophrenia and schizo-affective psychosis.".
- 76010396 extent "xii, 415 p. :".
- 76010396 identifier "0444152059 (Amer. Elsevier)".
- 76010396 isPartOf "Ciba Foundation symposium ; 39 (new ser.)".
- 76010396 isPartOf "Ciba Foundation. Symposium ; new ser., 39.".
- 76010396 issued "1976".
- 76010396 issued "1976.".
- 76010396 language "eng".
- 76010396 publisher "Amsterdam ; New York : Elsevier/Excerpta Medica/North-Holland,".
- 76010396 subject "612/.0151/8".
- 76010396 subject "Monoamine oxidase Congresses.".
- 76010396 subject "Monoamine oxidase Inhibitors Congresses.".
- 76010396 subject "Monoamine oxidase inhibitors Congresses.".
- 76010396 subject "QP603.M6 S95 1975".
- 76010396 subject "W3 C161F v. 39 QU135 M7503".
- 76010396 tableOfContents "Kety, S.S. Introduction.--Tipton, K. F., Houslay, M.D., and Mantle, T.J. The nature and locations of the multiple forms of monamine oxidase.--Maycock, A.L. et al. The action of acetylenic inhibitors on mitochondrial monoamine oxidase: structure of the flavin site in the inhibited enzyme.--Salach, J.I. et al. Cysteinyl flavin in monamine oxidase from the central nervous system.--Gorkin, V.Z. Monoamine oxidase inhibitors and the transformation of monoamine oxidases.--Sourkes, T.L. and Missala, K. Nutritional requirements for amine metabolism in vivo.--Youdim, M.B.H. and Holzbauer, M. Physiological aspects of the oxidative deamination of monoamines.--Knoll, J. Analysis of the pharmacological effects of selective monoamine oxidase inhibitors.--Neff, N.H. and Fuentes, J.A. The use of selective monoamine oxidase inhibitor drugs for evaluating pharmacological and physiological mechanisms.--Trendelenburg, U., Graefe, K.H., and Henseling, M. The part played by monoamine oxidase in the inactivation of catecholamines in intact tissues.--Sharman, D.F. Can the intra- and extra-homoneuronal metabolism of catecholamines be distinguished in the mammalian central nervous system?--Green, A.R. and Youdim, M.B.H. Use of a behavioural model to study the action of monoamine oxidase inhibition in vivo.--Maitre, L., Delini-Stula, A., and Waldmeier, P.C. Relations between the degree of monoamine oxidase inhibition and some psychopharmacological responses to monoamine oxidase inhibitors in rats.--Pare, C.M.B. Introduction to clinical aspects of monoamine oxidase inhibitors in the treatment of depression.--Roth, M. et al. The relationship between classification and response to drugs in affective disorders--problems posed by drug response in affective disorders.--Sandler, M. Variations in monoamine oxidase activity in some human disease states.--Murphy, D.L. Clinical, genetic, hormonal and drug influences on the activity of human platelet monoamine oxidase activity in schizophrenia and schizo-affective psychosis.".
- 76010396 title "Monoamine oxidase and its inhibition : in honour of Mary L. C. Bernheim.".
- 76010396 type "text".